Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR3 | P49019 | 8/20 | 0.70 |
| ▸ | HPGD | P15428 | 3/20 | 0.70 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.70 |
| ▸ | MAPT | P10636 | 4/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20587465 | 1.00 | HCAR3 (0.70) | HCAR3HPGDHCAR2MAPTPOLB | |
| SCHEMBL20588071 | 0.84 | HCAR3 (0.76) | HCAR3HPGDHCAR2MAPTPOLB | |
| SCHEMBL839123 | 0.82 | HCAR3 (1.00) | HCAR3HPGDHCAR2 | |
| SCHEMBL10242669 | 0.82 | HCAR3 (0.78) | HCAR3HPGDHCAR2MAPTPOLB | |
| SCHEMBL20587471 | 0.82 | HCAR3 (0.72) | HCAR3HPGDHCAR2MAPTPOLB | |
| SCHEMBL29069383 | 0.81 | MAPT (0.70) | HCAR3HPGDMAPTPOLBRAB9A | |
| SCHEMBL1020492 | 0.81 | HCAR3 (0.76) | HCAR3HPGDHCAR2MAPTPOLB | |
| SCHEMBL30767829 | 0.81 | MAPT (0.70) | HCAR3HPGDMAPTPOLBRAB9A | |
| SCHEMBL23657546 | 0.80 | RAB9A (0.72) | HCAR3HPGDHCAR2MAPTPOLB | |
| SCHEMBL20587483 | 0.78 | HCAR3 (0.67) | HCAR3HPGDHCAR2MAPTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114585360-B | Methods of using the same for treating epilepsy | 特维娜有限公司 | 2025-04-29 | — | — | CN | disclosed |
| EP-4025211-A1 | METHODS OF TREATING EPILEPSY USING THE SAME | Trevena, Inc. (US) | 2022-07-13 | — | — | EP | disclosed |
| CN-114585360-A | Methods of using the same for the treatment of epilepsy | 特维娜有限公司 | 2022-06-03 | — | — | CN | disclosed |